| Old Articles: <Older 10111-10120 Newer> |
 |
The Motley Fool October 14, 2005 Stephen D. Simpson |
First Data Tests Patience Great moat, good cash flow, lackluster growth. What's an investor to do?  |
The Motley Fool October 14, 2005 Stephen D. Simpson |
UnitedHealth Still in the Pink Growth will moderate, but this strong cash-generating health insurance company should continue to reward investors.  |
The Motley Fool October 14, 2005 Jack Uldrich |
A TINY Alternative in Nanotech Arrowhead Research offers individual investors who are looking to profit from nanotechnology an alternative to Harris & Harris.  |
The Motley Fool October 14, 2005 Rich Duprey |
Will FormFactor Test Positive? The manufacturer of advanced test probe cards will look to new plant for future gains. Investors have a chance to buy in to an industry leader that has positioned itself for further growth down the line.  |
The Motley Fool October 14, 2005 Amanda Tyler |
Ahoy, Alloy! A direct marketer who dabbled in retailing returns to basics. Investors, take note.  |
The Motley Fool October 14, 2005 Stephen D. Simpson |
Sleep Well With BB&T This bank likely won't ever be a hot tip, but steady performance has a role in almost all portfolios.  |
The Motley Fool October 14, 2005 Nathan Parmelee |
Bank on This Yield The long-term outperformance of the banking industry and historical strong growth in dividends make banks a natural fit for an investor seeking growth and dividend income.  |
The Motley Fool October 14, 2005 Rich Smith |
Well-Received Ambassadors The little travel coordinator Ambassadors Group, Siamese twin to event manager Ambassadors International, posted its third-quarter 2005 earnings. They were, in a word, stellar.  |
The Motley Fool October 14, 2005 Rich Smith |
Apollo: Back to Square One This education stock comes full circle, but the valuation isn't at the right place yet.  |
The Motley Fool October 14, 2005 S.J. Caplan |
"Unconventional Success": Conventional Foolishness David Swensen's new investment book, Unconventional Success: A Fundamental Approach to Personal Investment, offers good advice, but what's the intended audience?  |
| <Older 10111-10120 Newer> Return to current articles. |